{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:38:39Z","timestamp":1789094319140,"version":"build-2803163510"},"reference-count":179,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ncff5626","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T06:07:26Z","timestamp":1754892446000},"page":"5718-5745","source":"Crossref","is-referenced-by-count":4,"title":["The role of apoptosis and its potential as a therapeutic target in inflammatory bowel disease associated with colorectal cancer"],"prefix":"10.62347","volume":"17","author":[{"given":"Chuxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"JF","year":"1972","unstructured":"Kerr JF, Wyllie AH and Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.","journal-title":"Br J Cancer"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physrev.00027.2003","article-title":"Apoptosis and dependence receptors: a molecular basis for cellular addiction","volume":"84","author":"DE","year":"2004","unstructured":"Bredesen DE, Mehlen P and Rabizadeh S. Apoptosis and dependence receptors: a molecular basis for cellular addiction. Physiol Rev 2004; 84: 411-30.","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E and Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 2021; 18: 1106-1121.","journal-title":"Cell Mol Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.32604\/biocell.2024.048311","article-title":"How aging affects bone health via the intestinal micro-environment","volume":"48","author":"Hu","year":"2024","unstructured":"Hu H, Huang Y, Liu F, Wang Q and Yao Y. How aging affects bone health via the intestinal micro-environment. Biocell 2024; 48: 353-362.","journal-title":"Biocell"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/01.MIB.0000217334.30689.3e","article-title":"Regulation of apoptosis during homeostasis and disease in the intestinal epithelium","volume":"12","author":"Edelblum","year":"2006","unstructured":"Edelblum KL, Yan F, Yamaoka T and Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 2006; 12: 413-24.","journal-title":"Inflamm Bowel Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1242\/jcs.107.12.3569","article-title":"Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis","volume":"107","author":"Hall","year":"1994","unstructured":"Hall PA, Coates PJ, Ansari B and Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-77.","journal-title":"J Cell Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/ueg2.12317","article-title":"Implications of the changing epidemiology of inflammatory bowel disease in a changing world","volume":"10","author":"Agrawal","year":"2022","unstructured":"Agrawal M and Jess T. Implications of the changing epidemiology of inflammatory bowel disease in a changing world. United European Gastroenterol J 2022; 10: 1113-1120.","journal-title":"United European Gastroenterol J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7819824","DOI":"10.1155\/2020\/7819824","article-title":"The achievements and challenges of mesenchymal stem cell-based therapy in inflammatory bowel disease and its associated colorectal cancer","volume":"2020","author":"Ocansey","year":"2020","unstructured":"Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, Xu W and Mao F. The achievements and challenges of mesenchymal stem cell-based therapy in inflammatory bowel disease and its associated colorectal cancer. Stem Cells Int 2020; 2020: 7819824.","journal-title":"Stem Cells Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1172\/JCI97912","article-title":"Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure","volume":"128","author":"Armacki","year":"2018","unstructured":"Armacki M, Trugenberger AK, Ellwanger AK, Eiseler T, Schwerdt C, Bettac L, Langgartner D, Azoitei N, Halbgebauer R, Groß R, Barth T, Lechel A, Walter BM, Kraus JM, Wiegreffe C, Grimm J, Scheffold A, Schneider MR, Peuker K, Zeißig S, Britsch S, Rose-John S, Vettorazzi S, Wolf E, Tannapfel A, Steinestel K, Reber SO, Walther P, Kestler HA, Radermacher P, Barth TF, Huber-Lang M, Kleger A and Seufferlein T. Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure. J Clin Invest 2018; 128: 5056-5072.","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wang M, Huang Q, Liu M, Zhao T, Song X, Chen Q, Yang Y, Nan Y, Liu Z, Zhang Y, Wu W and Ai K. Precisely inhibiting excessive intestinal epithelial cell apoptosis to efficiently treat inflammatory bowel disease with oral pifithrin-α embedded nanomedicine (OPEN). Adv Mater 2023; 35: e2309370.","DOI":"10.1002\/adma.202309370"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fphar.2020.00438","article-title":"Apoptosis exerts a vital role in the treatment of colitis-associated cancer by herbal medicine","volume":"11","author":"Tian","year":"2020","unstructured":"Tian R, Liu X, Luo Y, Jiang S, Liu H, You F, Zheng C and Wu J. Apoptosis exerts a vital role in the treatment of colitis-associated cancer by herbal medicine. Front Pharmacol 2020; 11: 438.","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A and Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49-63.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","article-title":"Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c","volume":"86","author":"Liu","year":"1996","unstructured":"Liu X, Kim CN, Yang J, Jemmerson R and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-89.","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1083\/jcb.144.2.281","article-title":"Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner","volume":"144","author":"Slee","year":"1999","unstructured":"Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144: 281-92.","journal-title":"J Cell Biol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0968-0004(97)01085-2","article-title":"Caspases: killer proteases","volume":"22","author":"Nicholson","year":"1997","unstructured":"Nicholson DW and Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997; 22: 299-306.","journal-title":"Trends Biochem Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0092-8674(00)81005-3","article-title":"A license to kill","volume":"85","author":"Fraser","year":"1996","unstructured":"Fraser A and Evan G. A license to kill. Cell 1996; 85: 781-4.","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Wang K, Sun Q, Zhong X, Zeng M, Zeng H, Shi X, Li Z, Wang Y, Zhao Q, Shao F and Ding J. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell 2020; 180: 941-955, e20.","DOI":"10.1016\/j.cell.2020.02.002"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1038\/s41467-020-18443-3","article-title":"Indirect regulation of HMGB1 release by gasdermin D","volume":"11","author":"Volchuk","year":"2020","unstructured":"Volchuk A, Ye A, Chi L, Steinberg BE and Goldenberg NM. Indirect regulation of HMGB1 release by gasdermin D. Nat Commun 2020; 11: 4561.","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0092-8674(00)80943-5","article-title":"Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE","volume":"92","author":"Wang","year":"1998","unstructured":"Wang S, Miura M, Jung YK, Zhu H, Li E and Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-9.","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","unstructured":"Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M and Dixit VM. Non-canonical inflammasome activation targets caspase-11. Nature 2011; 479: 117-21.","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.1230751","article-title":"Caspase-11 protects against bacteria that escape the vacuole","volume":"339","author":"Aachoui","year":"2013","unstructured":"Aachoui Y, Leaf IA, Hagar JA, Fontana MF, Campos CG, Zak DE, Tan MH, Cotter PA, Vance RE, Aderem A and Miao EA. Caspase-11 protects against bacteria that escape the vacuole. Science 2013; 339: 975-8.","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.1240988","article-title":"Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock","volume":"341","author":"Hagar","year":"2013","unstructured":"Hagar JA, Powell DA, Aachoui Y, Ernst RK and Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013; 341: 1250-3.","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"341","author":"Kayagaki","year":"2013","unstructured":"Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszyński A, Forsberg LS, Carlson RW and Dixit VM. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013; 341: 1246-9.","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Lemarie A and Grimm S. Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer? Oncogene 2011; 30: 3985-4003.","DOI":"10.1038\/onc.2011.167"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","article-title":"Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors","volume":"94","author":"Luo","year":"1998","unstructured":"Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"Kang","year":"2009","unstructured":"Kang MH and Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009; 15: 1126-32.","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","unstructured":"Kale J, Osterlund EJ and Andrews DW. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ 2018; 25: 65-80.","journal-title":"Cell Death Differ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/BCJ20210854","article-title":"The concept of intrinsic versus extrinsic apoptosis","volume":"479","author":"Lossi","year":"2022","unstructured":"Lossi L. The concept of intrinsic versus extrinsic apoptosis. Biochem J 2022; 479: 357-384.","journal-title":"Biochem J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.275.5302.983","article-title":"Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis","volume":"275","author":"Sattler","year":"1997","unstructured":"Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB and Fesik SW. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997; 275: 983-6.","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Diepstraten ST, Yuan Y, La Marca JE, Young S, Chang C, Whelan L, Ross AM, Fischer KC, Pomilio G, Morris R, Georgiou A, Litalien V, Brown FC, Roberts AW, Strasser A, Wei AH and Kelly GL. Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers. Cancer Cell 2024; 42: 850-868, e9.","DOI":"10.1016\/j.ccell.2024.04.004"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1074\/jbc.273.10.5841","article-title":"Dixit, Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex","volume":"273","author":"Pan","year":"1998","unstructured":"Pan G, O’Rourke K and Dixit VM. Dixit, Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem 1998; 273: 5841-5.","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Fairbrother WJ, Leverson JD and Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 2017; 16: 273-284.","journal-title":"Nat Rev Drug Discov"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nrm1496","article-title":"Molecular mechanisms of caspase regulation during apoptosis","volume":"5","author":"Riedl","year":"2004","unstructured":"Riedl SJ and Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1158\/0008-5472.CAN-14-3652","article-title":"Dependence receptors and cancer: addiction to trophic ligands","volume":"75","author":"Gibert","year":"2015","unstructured":"Gibert B and Mehlen P. Dependence receptors and cancer: addiction to trophic ligands. Cancer Res 2015; 75: 5171-5.","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1071553","article-title":"The Fas signaling pathway: more than a paradigm","volume":"296","author":"Wajant","year":"2002","unstructured":"Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002; 296: 1635-6.","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Green DR. The death receptor pathway of apoptosis. Cold Spring Harb Perspect Biol 2022; 14: a041053.","DOI":"10.1101\/cshperspect.a041053"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","article-title":"Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation","volume":"73","author":"DW","year":"1993","unstructured":"Banner DW, D’Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H and Lesslauer W. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993; 73: 431-45.","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1074\/jbc.273.8.4345","article-title":"Membrane oligomerization and cleavage activates the caspase-8 (FLICE\/MACHalpha1) death signal","volume":"273","author":"Martin","year":"1998","unstructured":"Martin DA, Siegel RM, Zheng L and Lenardo MJ. Membrane oligomerization and cleavage activates the caspase-8 (FLICE\/MACHalpha1) death signal. J Biol Chem 1998; 273: 4345-9.","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","unstructured":"Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-5.","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/44617","article-title":"NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP","volume":"401","author":"Sun","year":"1999","unstructured":"Sun C, Cai M, Gunasekera AH, Meadows RP, Wang H, Chen J, Zhang H, Wu W, Xu N, Ng SC and Fesik SW. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 1999; 401: 818-22.","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","unstructured":"Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-70.","journal-title":"Mol Cell"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1097-2765(03)00054-6","article-title":"Mechanism of XIAP-mediated inhibition of caspase-9","volume":"11","author":"Shiozaki","year":"2003","unstructured":"Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, Alnemri ES, Fairman R and Shi Y. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003; 11: 519-27.","journal-title":"Mol Cell"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"22005","DOI":"10.1074\/jbc.M115.643064","article-title":"Bax\/Bak-dependent, Drp1-independent targeting of X-linked inhibitor of apoptosis protein (XIAP) into Inner mitochondrial compartments counteracts smac\/DIABLO-dependent effector caspase activation","volume":"290","author":"Hamacher-Brady","year":"2015","unstructured":"Hamacher-Brady A and Brady NR. Bax\/Bak-dependent, Drp1-independent targeting of X-linked inhibitor of apoptosis protein (XIAP) into Inner mitochondrial compartments counteracts smac\/DIABLO-dependent effector caspase activation. J Biol Chem 2015; 290: 22005-18.","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"24295","DOI":"10.1074\/jbc.C800128200","article-title":"c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation","volume":"283","author":"Varfolomeev","year":"2008","unstructured":"Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ and Vucic D. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008; 283: 24295-9.","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/35065125","article-title":"A conserved XIAP-interaction motif in caspase-9 and Smac\/DIABLO regulates caspase activity and apoptosis","volume":"410","author":"Srinivasula","year":"2001","unstructured":"Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y and Alnemri ES. A conserved XIAP-interaction motif in caspase-9 and Smac\/DIABLO regulates caspase activity and apoptosis. Nature 2001; 410: 112-6.","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Fulda","year":"2012","unstructured":"Fulda S and Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov 2012; 11: 109-24.","journal-title":"Nat Rev Drug Discov"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Zhao JT, Zheng X, Rao GW and Zheng Q. Research progress in the use of small molecule smac mimetics in combination therapy of cancer. Curr Med Chem 2024; [Epub ahead of print].","DOI":"10.2174\/0109298673283734240206020150"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.gendis.2018.07.002","article-title":"Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine","volume":"5","author":"Qin","year":"2018","unstructured":"Qin JJ, Li X, Hunt C, Wang W, Wang H and Zhang R. Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine. Genes Dis 2018; 5: 204-219.","journal-title":"Genes Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","unstructured":"Vousden KH and Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413-31.","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/sj.cdd.4401916","article-title":"Transcriptional regulation by p53: one protein, many possibilities","volume":"13","author":"Laptenko","year":"2006","unstructured":"Laptenko O and Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006; 13: 951-61.","journal-title":"Cell Death Differ"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.tcb.2009.10.002","article-title":"Transcription-independent p53 apoptosis: an alternative route to death","volume":"20","author":"Speidel","year":"2010","unstructured":"Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 2010; 20: 14-24.","journal-title":"Trends Cell Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1126\/science.1252809","article-title":"Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure","volume":"344","author":"Segawa","year":"2014","unstructured":"Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F and Nagata S. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 2014; 344: 1164-8.","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"13305","DOI":"10.1074\/jbc.M113.457937","article-title":"Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members","volume":"288","author":"Suzuki","year":"2013","unstructured":"Suzuki J, Fujii T, Imao T, Ishihara K, Kuba H and Nagata S. Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. J Biol Chem 2013; 288: 13305-16.","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","article-title":"Apoptosis and clearance of apoptotic cells","volume":"36","author":"Nagata","year":"2018","unstructured":"Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol 2018; 36: 489-517.","journal-title":"Annu Rev Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2121-3","article-title":"Metabolites released from apoptotic cells act as tissue messengers","volume":"580","author":"CB","year":"2020","unstructured":"Medina CB, Mehrotra P, Arandjelovic S, Perry JSA, Guo Y, Morioka S, Barron B, Walk SF, Ghesquière B, Krupnick AS, Lorenz U and Ravichandran KS. Metabolites released from apoptotic cells act as tissue messengers. Nature 2020; 580: 130-135.","journal-title":"Nature"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.abi5934","article-title":"Dying cells fan the flames of inflammation","volume":"374","author":"Newton","year":"2021","unstructured":"Newton K, Dixit VM and Kayagaki N. Dying cells fan the flames of inflammation. Science 2021; 374: 1076-1080.","journal-title":"Science"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.physiol.010908.163145","article-title":"Clevers, stem cells, self-renewal, and differentiation in the intestinal epithelium","volume":"71","author":"van der Flier","year":"2009","unstructured":"van der Flier LG and Clevers H. Clevers, stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009; 71: 241-60.","journal-title":"Annu Rev Physiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ceb.2003.10.012","article-title":"Live and let die in the intestinal epithelium","volume":"15","author":"Sancho","year":"2003","unstructured":"Sancho E, Batlle E and Clevers H. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 2003; 15: 763-70.","journal-title":"Curr Opin Cell Biol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/gutjnl-2011-301364","article-title":"Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium","volume":"62","author":"Gü","year":"2013","unstructured":"Günther C, Neumann H, Neurath MF and Becker C. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 2013; 62: 1062-71.","journal-title":"Gut"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4161\/gmic.1.6.14076","article-title":"Paneth cell defensins and the regulation of the microbiome: détente at mucosal surfaces","volume":"1","author":"Salzman","year":"2010","unstructured":"Salzman NH. Paneth cell defensins and the regulation of the microbiome: détente at mucosal surfaces. Gut Microbes 2010; 1: 401-6.","journal-title":"Gut Microbes"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrmicro2546","article-title":"Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis","volume":"9","author":"Bevins","year":"2011","unstructured":"Bevins CL and Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011; 9: 356-68.","journal-title":"Nat Rev Microbiol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"103717","DOI":"10.1016\/j.autrev.2024.103717","article-title":"Intestinal mucus barrier: a potential therapeutic target for IBD","volume":"24","author":"Qiao","year":"2025","unstructured":"Qiao Y, He C, Xia Y, Ocansey DKW and Mao F. Intestinal mucus barrier: a potential therapeutic target for IBD. Autoimmun Rev 2025; 24: 103717.","journal-title":"Autoimmun Rev"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/MED.0000000000000709","article-title":"Enteroendocrine cell differentiation and function in the intestine","volume":"29","author":"JG","year":"2022","unstructured":"Sanchez JG, Enriquez JR and Wells JM. Enteroendocrine cell differentiation and function in the intestine. Curr Opin Endocrinol Diabetes Obes 2022; 29: 169-176.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1111\/febs.13771","article-title":"Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease","volume":"283","author":"Blander","year":"2016","unstructured":"Blander JM. Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. FEBS J 2016; 283: 2720-30.","journal-title":"FEBS J"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","article-title":"Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts","volume":"469","author":"Sato","year":"2011","unstructured":"Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M and Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011; 469: 415-8.","journal-title":"Nature"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF01868675","article-title":"Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions","volume":"116","author":"Madara","year":"1990","unstructured":"Madara JL. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J Membr Biol 1990; 116: 177-84.","journal-title":"J Membr Biol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s10350-004-6802-z","article-title":"Increased enterocyte apoptosis in inflamed areas of Crohn’s disease","volume":"46","author":"Di Sabatino","year":"2003","unstructured":"Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, Solcia E and Corazza GR. Increased enterocyte apoptosis in inflamed areas of Crohn’s disease. Dis Colon Rectum 2003; 46: 1498-507.","journal-title":"Dis Colon Rectum"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1046\/j.1440-1746.2002.02791.x","article-title":"Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery","volume":"17","author":"Hagiwara","year":"2002","unstructured":"Hagiwara C, Tanaka M and Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol 2002; 17: 758-64.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref69","unstructured":"Subramanian S, Geng H and Tan XD. Cell death of intestinal epithelial cells in intestinal diseases. Sheng Li Xue Bao 2020; 72: 308-324."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1172\/JCI42917","article-title":"PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice","volume":"121","author":"Qiu","year":"2011","unstructured":"Qiu W, Wu B, Wang X, Buchanan ME, Regueiro MD, Hartman DJ, Schoen RE, Yu J and Zhang L. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest 2011; 121: 1722-32.","journal-title":"J Clin Invest"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/(SICI)1096-9896(199610)180:2<152::AID-PATH649>3.0.CO;2-Y","article-title":"Apoptosis of crypt epithelial cells in ulcerative colitis","volume":"180","author":"Iwamoto","year":"1996","unstructured":"Iwamoto M, Koji T, Makiyama K, Kobayashi N and Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996; 180: 152-9.","journal-title":"J Pathol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014; 14: 329-42.","journal-title":"Nat Rev Immunol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/intimm\/dxu051","article-title":"Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation","volume":"26","author":"Leppkes","year":"2014","unstructured":"Leppkes M, Roulis M, Neurath MF, Kollias G and Becker C. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation. Int Immunol 2014; 26: 509-15.","journal-title":"Int Immunol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D’Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK and Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC and Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-24.","journal-title":"Nature"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","unstructured":"Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F and Kollias G. Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387-98.","journal-title":"Immunity"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/CS20100027","article-title":"T-cell-directed therapies in inflammatory bowel diseases","volume":"118","author":"Monteleone","year":"2010","unstructured":"Monteleone G and Caprioli F. T-cell-directed therapies in inflammatory bowel diseases. Clin Sci (Lond) 2010; 118: 707-15.","journal-title":"Clin Sci (Lond)"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.5114\/aoms.2015.54203","article-title":"Disturbances in apoptosis of lamina propria lymphocytes in Crohn’s disease","volume":"11","author":"Eder","year":"2015","unstructured":"Eder P, Łykowska-Szuber L, Krela-Kaźmierczak I, Stawczyk-Eder K, Iwanik K, Majewski P, Sterzyńska K, Zabel M and Linke K. Disturbances in apoptosis of lamina propria lymphocytes in Crohn’s disease. Arch Med Sci 2015; 11: 1279-85.","journal-title":"Arch Med Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/gut.2010.217117","article-title":"Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment","volume":"60","author":"Veltkamp","year":"2011","unstructured":"Veltkamp C, Anstaett M, Wahl K, Möller S, Gangl S, Bachmann O, Hardtke-Wolenski M, Länger F, Stremmel W, Manns MP, Schulze-Osthoff K and Bantel H. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment. Gut 2011; 60: 1345-53.","journal-title":"Gut"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/mib.0000000000000384","article-title":"Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD","volume":"21","author":"Lissner","year":"2015","unstructured":"Lissner D, Schumann M, Batra A, Kredel LI, Kühl AA, Erben U, May C, Schulzke JD and Siegmund B. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis 2015; 21: 1297-305.","journal-title":"Inflamm Bowel Dis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.gastro.2018.09.041","article-title":"Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency","volume":"156","author":"AS","year":"2019","unstructured":"Lehle AS, Farin HF, Marquardt B, Michels BE, Magg T, Li Y, Liu Y, Ghalandary M, Lammens K, Hollizeck S, Rohlfs M, Hauck F, Conca R, Walz C, Weiss B, Lev A, Simon AJ, Groß O, Gaidt MM, Hornung V, Clevers H, Yazbeck N, Hanna-Wakim R, Shouval DS, Warner N, Somech R, Muise AM, Snapper SB, Bufler P, Koletzko S, Klein C and Kotlarz D. Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency. Gastroenterology 2019; 156: 275-278.","journal-title":"Gastroenterology"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-020-2796-5","article-title":"Integration of innate immune signalling by caspase-8 cleavage of N4BP1","volume":"587","author":"Gitlin","year":"2020","unstructured":"Gitlin AD, Heger K, Schubert AF, Reja R, Yan D, Pham VC, Suto E, Zhang J, Kwon YC, Freund EC, Kang J, Pham A, Caothien R, Bacarro N, Hinkle T, Xu M, McKenzie BS, Haley B, Lee WP, Lill JR, Roose-Girma M, Dohse M, Webster JD, Newton K and Dixit VM. Integration of innate immune signalling by caspase-8 cleavage of N4BP1. Nature 2020; 587: 275-280.","journal-title":"Nature"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature10273","article-title":"FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation","volume":"477","author":"PS","year":"2011","unstructured":"Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernández-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G and Pasparakis M. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011; 477: 330-4.","journal-title":"Nature"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature05698","article-title":"Epithelial NEMO links innate immunity to chronic intestinal inflammation","volume":"446","author":"Nenci","year":"2007","unstructured":"Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, Gumucio D, Neurath MF and Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007; 446: 557-61.","journal-title":"Nature"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Ahn JH, da Silva Pedrosa M, Lopez LR, Tibbs TN, Jeyachandran JN, Vignieri EE, Rothemich A, Cumming I, Irmscher AD, Haswell CJ, Zamboni WC, Yu YA, Ellermann M, Denson LA and Arthur JC. Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn’s disease. Cell Host Microbe 2025; 33: 71-88, e9.","DOI":"10.1016\/j.chom.2024.11.012"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Schölmerich J and Huber G. Biological therapy in IBD. Anti-tumor necrosis factor-alpha and others. Dig Dis 2003; 21: 180-91.","DOI":"10.1159\/000073249"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF and Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s disease cA2 study group. N Engl J Med 1997; 337: 1029-35.","DOI":"10.1056\/NEJM199710093371502"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE and Colombel JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-76.","journal-title":"N Engl J Med"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/gut.2003.036632","article-title":"Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor alpha antibody treatment","volume":"53","author":"Zeissig","year":"2004","unstructured":"Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M and Schulzke JD. Downregulation of epithelial apoptosis and barrier repair in active Crohn’s disease by tumour necrosis factor alpha antibody treatment. Gut 2004; 53: 1295-302.","journal-title":"Gut"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1572-0241.2002.05914.x","article-title":"Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease","volume":"97","author":"Suenaert","year":"2002","unstructured":"Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL and Rutgeerts P. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol 2002; 97: 2000-4.","journal-title":"Am J Gastroenterol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"NR","year":"2017","unstructured":"West NR, Hegazy AN, Owens BMJ, Bullers SJ, Linggi B, Buonocore S, Coccia M, Görtz D, This S, Stockenhuber K, Pott J, Friedrich M, Ryzhakov G, Baribaud F, Brodmerkel C, Cieluch C, Rahman N, Müller-Newen G, Owens RJ, Kühl AA, Maloy KJ and Plevy SE; Oxford IBD Cohort Investigators; Keshav S, Travis SPL and Powrie F. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med 2017; 23: 579-589.","journal-title":"Nat Med"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes","volume":"116","author":"GC","year":"1999","unstructured":"Kaiser GC, Yan F and Polk DB. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes. Gastroenterology 1999; 116: 602-9.","journal-title":"Gastroenterology"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"36631","DOI":"10.1074\/jbc.274.51.36631","article-title":"Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells","volume":"274","author":"Yan","year":"1999","unstructured":"Yan F and Polk DB. Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells. J Biol Chem 1999; 274: 36631-6.","journal-title":"J Biol Chem"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Mukherjee T, Kumar N, Chawla M, Philpott DJ and Basak S. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease. Sci Signal 2024; 17: eadh1641.","DOI":"10.1126\/scisignal.adh1641"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1046\/j.1365-2036.2003.01603.x","article-title":"Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition","volume":"17","author":"Rutgeerts","year":"2003","unstructured":"Rutgeerts P, Van Deventer S and Schreiber S. Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition. Aliment Pharmacol Ther 2003; 17: 1435-50.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","unstructured":"Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S and Neurath MF. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 2000; 6: 583-8.","journal-title":"Nat Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.32604\/biocell.2024.056503","article-title":"Targeting cell cycle regulators: a new paradigm in cancer therapeutics","volume":"48","author":"Singh","year":"2024","unstructured":"Singh G, Sharma S, Mishra N, Soni A, Kumari M and Singh S. Targeting cell cycle regulators: a new paradigm in cancer therapeutics. Biocell 2024; 48: 1639-1666.","journal-title":"Biocell"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A and D’Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 2016; 8: 603-19.","journal-title":"Aging (Albany NY)"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1083\/jcb.200204039","article-title":"Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms","volume":"157","author":"Morgan","year":"2002","unstructured":"Morgan M, Thorburn J, Pandolfi PP and Thorburn A. Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. J Cell Biol 2002; 157: 975-84.","journal-title":"J Cell Biol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10528-021-10060-z","article-title":"Association of TNFRSF1A and IFNLR1 gene polymorphisms with the risk of developing breast cancer and clinical pathologic features","volume":"59","author":"Hausmann","year":"2021","unstructured":"Hausmann LD, de Almeida BS, de Souza IR, Drehmer MN, Fernandes BL, Wilkens RS, Vieira DSC, Lofgren SE, Lindenau JD, de Toledo E Silva G and Muniz YCN. Association of TNFRSF1A and IFNLR1 gene polymorphisms with the risk of developing breast cancer and clinical pathologic features. Biochem Genet 2021; 59: 1233-1246.","journal-title":"Biochem Genet"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"10434","DOI":"10.7150\/thno.47286","article-title":"HRG switches TNFR1-mediated cell survival to apoptosis in Hepatocellular Carcinoma","volume":"10","author":"Zou","year":"2020","unstructured":"Zou X, Zhang D, Song Y, Liu S, Long Q, Yao L, Li W, Duan Z, Wu D and Liu L. HRG switches TNFR1-mediated cell survival to apoptosis in Hepatocellular Carcinoma. Theranostics 2020; 10: 10434-10447.","journal-title":"Theranostics"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1365-2141.2001.03085.x","article-title":"Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis","volume":"115","author":"Brouwer","year":"2001","unstructured":"Brouwer RE, Hoefnagel J, Borger van Der Burg B, Jedema I, Zwinderman KH, Starrenburg IC, Kluin-Nelemans HC, Barge RM, Willemze R and Falkenburg JH. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis. Br J Haematol 2001; 115: 298-308.","journal-title":"Br J Haematol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.2294591","article-title":"Identification of a chromosome 18q gene that is altered in colorectal cancers","volume":"247","author":"Fearon","year":"1990","unstructured":"Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247: 49-56.","journal-title":"Science"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/386796a0","article-title":"Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene","volume":"386","author":"Fazeli","year":"1997","unstructured":"Fazeli A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M and Weinberg RA. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 1997; 386: 796-804.","journal-title":"Nature"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ng0796-343","article-title":"Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers","volume":"13","author":"Thiagalingam","year":"1996","unstructured":"Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW and Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996; 13: 343-6.","journal-title":"Nat Genet"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.biocel.2009.11.015","article-title":"Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer","volume":"42","author":"Bagnoli","year":"2010","unstructured":"Bagnoli M, Canevari S and Mezzanzanica D. Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer. Int J Biochem Cell Biol 2010; 42: 210-3.","journal-title":"Int J Biochem Cell Biol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2010.10.009","article-title":"Targeting c-FLIP in cancer","volume":"332","author":"Shirley","year":"2013","unstructured":"Shirley S and Micheau O. Targeting c-FLIP in cancer. Cancer Lett 2013; 332: 141-50.","journal-title":"Cancer Lett"},{"key":"ref107","unstructured":"Foreman KE, Wrone-Smith T, Boise LH, Thompson CB, Polverini PJ, Simonian PL, Nunez G and Nickoloff BJ. Kaposi’s sarcoma tumor cells preferentially express Bcl-xL. Am J Pathol 1996; 149: 795-803."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.V86.5.1903.bloodjournal8651903","article-title":"Expression of bcl-xL can confer a multidrug resistance phenotype","volume":"86","author":"Minn","year":"1995","unstructured":"Minn AJ, Rudin CM, Boise LH and Thompson CB. Expression of bcl-xL can confer a multidrug resistance phenotype. Blood 1995; 86: 1903-10.","journal-title":"Blood"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1309\/JQ2X3RV3L8F9TGYW","article-title":"Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability","volume":"123","author":"Miquel","year":"2005","unstructured":"Miquel C, Borrini F, Grandjouan S, Aupérin A, Viguier J, Velasco V, Duvillard P, Praz F and Sabourin JC. Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability. Am J Clin Pathol 2005; 123: 562-70.","journal-title":"Am J Clin Pathol"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Hasbullah HH and Musa M. Gene therapy targeting p53 and KRAS for colorectal cancer treatment: a myth or the way forward? Int J Mol Sci 2021; 22: 11941.","DOI":"10.3390\/ijms222111941"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1038\/s41388-018-0352-7","article-title":"LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation","volume":"37","author":"Zeng","year":"2018","unstructured":"Zeng K, Chen X, Hu X, Liu X, Xu T, Sun H, Pan Y, He B and Wang S. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Oncogene 2018; 37: 5534-5551.","journal-title":"Oncogene"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/35022514","article-title":"Structural and biochemical basis of apoptotic activation by Smac\/DIABLO","volume":"406","author":"Chai","year":"2000","unstructured":"Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y. Structural and biochemical basis of apoptotic activation by Smac\/DIABLO. Nature 2000; 406: 855-62.","journal-title":"Nature"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/35050006","article-title":"Structural basis for binding of Smac\/DIABLO to the XIAP BIR3 domain","volume":"408","author":"Liu","year":"2000","unstructured":"Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T, Herrmann J, Wu JC and Fesik SW. Structural basis for binding of Smac\/DIABLO to the XIAP BIR3 domain. Nature 2000; 408: 1004-8.","journal-title":"Nature"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/35050012","article-title":"Structural basis of IAP recognition by Smac\/DIABLO","volume":"408","author":"Wu","year":"2000","unstructured":"Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X and Shi Y. Structural basis of IAP recognition by Smac\/DIABLO. Nature 2000; 408: 1008-12.","journal-title":"Nature"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-04-1918","article-title":"Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice","volume":"64","author":"Schimmer","year":"2004","unstructured":"Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004; 64: 7183-90.","journal-title":"Cancer Res"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/leu.2014.56","article-title":"Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities","volume":"28","author":"Fulda","year":"2014","unstructured":"Fulda S. Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities. Leukemia 2014; 28: 1414-22.","journal-title":"Leukemia"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","unstructured":"Yamakuchi M, Ferlito M and Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008; 105: 13421-6.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.yexmp.2015.06.014","article-title":"MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer","volume":"99","author":"Lu","year":"2015","unstructured":"Lu G, Sun Y, An S, Xin S, Ren X, Zhang D, Wu P, Liao W, Ding Y and Liang L. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer. Exp Mol Pathol 2015; 99: 173-9.","journal-title":"Exp Mol Pathol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"387","DOI":"10.32604\/biocell.2024.048791","article-title":"LncRNAs unraveling their sponge role in glioblastoma and potential therapeutic applications","volume":"48","author":"Liu","year":"2024","unstructured":"Liu C, Li X, Wu Y, Yang J, Wang M and Ma Y. LncRNAs unraveling their sponge role in glioblastoma and potential therapeutic applications. Biocell 2024; 48: 387-401.","journal-title":"Biocell"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.gendis.2020.04.009","article-title":"Functional roles of lncRNAs in the pathogenesis and progression of cancer","volume":"8","author":"Ahadi","year":"2021","unstructured":"Ahadi A. Functional roles of lncRNAs in the pathogenesis and progression of cancer. Genes Dis 2021; 8: 424-437.","journal-title":"Genes Dis"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/ijms16022472","article-title":"Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer","volume":"16","author":"JM","year":"2015","unstructured":"Ng JM and Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci 2015; 16: 2472-96.","journal-title":"Int J Mol Sci"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","article-title":"Gene body methylation can alter gene expression and is a therapeutic target in cancer","volume":"26","author":"Yang","year":"2014","unstructured":"Yang X, Han H, De Carvalho DD, Lay FD, Jones PA and Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 2014; 26: 577-90.","journal-title":"Cancer Cell"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00120-021-01569-7","article-title":"Management of chemotherapy side effects and their long-term sequelae","volume":"60","author":"Zraik","year":"2021","unstructured":"Zraik IM and Heß-Busch Y. Management of chemotherapy side effects and their long-term sequelae. Urologe A 2021; 60: 862-871.","journal-title":"Urologe A"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Ippolito MR, Martis V, Martin S, Tijhuis AE, Hong C, Wardenaar R, Dumont M, Zerbib J, Spierings DCJ, Fachinetti D, Ben-David U, Foijer F and Santaguida S. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy. Dev Cell 2021; 56: 2440-2454, e6.","DOI":"10.1016\/j.devcel.2021.07.006"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","article-title":"Drug resistance and new therapies in colorectal cancer","volume":"24","author":"Van der Jeught","year":"2018","unstructured":"Van der Jeught K, Xu HC, Li YJ, Lu XB and Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 2018; 24: 3834-3848.","journal-title":"World J Gastroenterol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/sj.cgt.7700792","article-title":"Mechanisms of resistance to TRAIL-induced apoptosis in cancer","volume":"12","author":"Zhang","year":"2005","unstructured":"Zhang L and Fang B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 2005; 12: 228-37.","journal-title":"Cancer Gene Ther"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0889-8588(02)00046-1","article-title":"Regulators of apoptosis as anticancer targets","volume":"16","author":"Tolcher","year":"2002","unstructured":"Tolcher AW. Regulators of apoptosis as anticancer targets. Hematol Oncol Clin North Am 2002; 16: 1255-67.","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref128","unstructured":"Ferreira CG, Epping M, Kruyt FA and Giaccone G. Apoptosis: target of cancer therapy. Clin Cancer Res 2002; 8: 2024-34."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"9893","DOI":"10.1038\/srep09893","article-title":"A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death","volume":"5","author":"Bucur","year":"2015","unstructured":"Bucur O, Gaidos G, Yatawara A, Pennarun B, Rupasinghe C, Roux J, Andrei S, Guo B, Panaitiu A, Pellegrini M, Mierke DF and Khosravi-Far R. A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death. Sci Rep 2015; 5: 9893.","journal-title":"Sci Rep"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Ghobrial IM, Witzig TE and Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55: 178-94.","DOI":"10.3322\/canjclin.55.3.178"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.moh.0000148552.93303.45","article-title":"Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies","volume":"12","author":"Chou","year":"2005","unstructured":"Chou WC and Dang CV. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr Opin Hematol 2005; 12: 1-6.","journal-title":"Curr Opin Hematol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1158\/1078-0432.CCR-15-2822","article-title":"DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1","volume":"22","author":"Ogitani","year":"2016","unstructured":"Ogitani Y, Aida T, Hagihara K, Yamaguchi J, Ishii C, Harada N, Soma M, Okamoto H, Oitate M, Arakawa S, Hirai T, Atsumi R, Nakada T, Hayakawa I, Abe Y and Agatsuma T. DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1. Clin Cancer Res 2016; 22: 5097-5108.","journal-title":"Clin Cancer Res"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"McGranahan N, Favero F, de Bruin EC, Birkbak NJ, Szallasi Z and Swanton C. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med 2015; 7: 283ra54.","DOI":"10.1126\/scitranslmed.aaa1408"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/hum.2017.218","article-title":"The first approved gene therapy product for cancer Ad-p53 (Gendicine): 12 years in the clinic","volume":"29","author":"Zhang","year":"2018","unstructured":"Zhang WW, Li L, Li D, Liu J, Li X, Li W, Xu X, Zhang MJ, Chandler LA, Lin H, Hu A, Xu W and Lam DM. The first approved gene therapy product for cancer Ad-p53 (Gendicine): 12 years in the clinic. Hum Gene Ther 2018; 29: 160-179.","journal-title":"Hum Gene Ther"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1566523220999200731003206","article-title":"Applications of recombinant adenovirus-p53 gene therapy for cancers in the clinic in China","volume":"20","author":"Xia","year":"2020","unstructured":"Xia Y, Li X and Sun W. Applications of recombinant adenovirus-p53 gene therapy for cancers in the clinic in China. Curr Gene Ther 2020; 20: 127-141.","journal-title":"Curr Gene Ther"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13046-023-02901-z","article-title":"CRISPR\/Cas9: a powerful tool in colorectal cancer research","volume":"42","author":"Hu","year":"2023","unstructured":"Hu Y, Liu L, Jiang Q, Fang W, Chen Y, Hong Y and Zhai X. CRISPR\/Cas9: a powerful tool in colorectal cancer research. J Exp Clin Cancer Res 2023; 42: 308.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-023-39156-3","article-title":"Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile","volume":"14","author":"Guo","year":"2023","unstructured":"Guo L, Hu C, Liu Y, Chen X, Song D, Shen R, Liu Z, Jia X, Zhang Q, Gao Y, Deng Z, Zuo T, Hu J, Zhu W, Cai J, Yan G, Liang J and Lin Y. Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile. Nat Commun 2023; 14: 3410.","journal-title":"Nat Commun"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"9761","DOI":"10.1021\/acs.nanolett.1c03708","article-title":"A duplex CRISPR-Cas9 ribonucleoprotein nanomedicine for colorectal cancer gene therapy","volume":"21","author":"Wan","year":"2021","unstructured":"Wan T, Pan Q, Liu C, Guo J, Li B, Yan X, Cheng Y and Ping Y. A duplex CRISPR-Cas9 ribonucleoprotein nanomedicine for colorectal cancer gene therapy. Nano Lett 2021; 21: 9761-9771.","journal-title":"Nano Lett"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13000-015-0264-6","article-title":"Decreased functional activity of multidrug resistance protein in primary colorectal cancer","volume":"10","author":"Micsik","year":"2015","unstructured":"Micsik T, Lőrincz A, Mersich T, Baranyai Z, Besznyák I Jr, Dede K, Zaránd A, Jakab F, Szöllösi LK, Kéri G, Schwab R and Peták I. Decreased functional activity of multidrug resistance protein in primary colorectal cancer. Diagn Pathol 2015; 10: 26.","journal-title":"Diagn Pathol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1002\/jcp.26356","article-title":"Reactive oxygen species and colorectal cancer","volume":"233","author":"Lin","year":"2018","unstructured":"Lin S, Li Y, Zamyatnin AA Jr, Werner J and Bazhin AV. Reactive oxygen species and colorectal cancer. J Cell Physiol 2018; 233: 5119-5132.","journal-title":"J Cell Physiol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/php.12857","article-title":"Cell death pathways associated with photodynamic therapy: an update","volume":"94","author":"Kessel","year":"2018","unstructured":"Kessel D and Oleinick NL. Cell death pathways associated with photodynamic therapy: an update. Photochem Photobiol 2018; 94: 213-218.","journal-title":"Photochem Photobiol"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.7150\/thno.51193","article-title":"Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer","volume":"11","author":"She","year":"2021","unstructured":"She T, Shi Q, Li Z, Feng Y, Yang H, Tao Z, Li H, Chen J, Wang S, Liang Y, Cheng J and Lu X. Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer. Theranostics 2021; 11: 4281-4297.","journal-title":"Theranostics"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1007\/s00432-023-04737-8","article-title":"Cancer immune escape: the role of antigen presentation machinery","volume":"149","author":"Kallingal","year":"2023","unstructured":"Kallingal A, Olszewski M, Maciejewska N, Brankiewicz W and Baginski M. Cancer immune escape: the role of antigen presentation machinery. J Cancer Res Clin Oncol 2023; 149: 8131-8141.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","unstructured":"Nakamura K and Smyth MJ. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol 2020; 17: 1-12.","journal-title":"Cell Mol Immunol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/imm.13520","article-title":"Human FOXP3 and tumour microenvironment","volume":"168","author":"Wang","year":"2023","unstructured":"Wang J, Gong R, Zhao C, Lei K, Sun X and Ren H. Human FOXP3 and tumour microenvironment. Immunology 2023; 168: 248-255.","journal-title":"Immunology"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2024.05.001","article-title":"Advancements in combining targeted therapy and immunotherapy for colorectal cancer","volume":"10","author":"Singh","year":"2024","unstructured":"Singh M, Morris VK, Bandey IN, Hong DS and Kopetz S. Advancements in combining targeted therapy and immunotherapy for colorectal cancer. Trends Cancer 2024; 10: 598-609.","journal-title":"Trends Cancer"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.2147\/CMAR.S212238","article-title":"Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer","volume":"11","author":"Liang","year":"2019","unstructured":"Liang H and Wang M. Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer. Cancer Manag Res 2019; 11: 7707-7719.","journal-title":"Cancer Manag Res"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11864-025-01306-8","article-title":"Enhancing colorectal cancer treatment through VEGF\/VEGFR inhibitors and immunotherapy","volume":"26","author":"Jiao","year":"2025","unstructured":"Jiao J, Wu Y, Wu S and Jiang J. Enhancing colorectal cancer treatment through VEGF\/VEGFR inhibitors and immunotherapy. Curr Treat Options Oncol 2025; 26: 213-225.","journal-title":"Curr Treat Options Oncol"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/cei.12069","article-title":"Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo","volume":"172","author":"Yasuda","year":"2013","unstructured":"Yasuda S, Sho M, Yamato I, Yoshiji H, Wakatsuki K, Nishiwada S, Yagita H and Nakajima Y. Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo. Clin Exp Immunol 2013; 172: 500-6.","journal-title":"Clin Exp Immunol"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"CD","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J and Pratz KW. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 2020; 383: 617-629.","journal-title":"N Engl J Med"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase ii study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","unstructured":"Konopleva M, Pollyea DA, Potluri J, Chyla B, Hogdal L, Busman T, McKeegan E, Salem AH, Zhu M, Ricker JL, Blum W, DiNardo CD, Kadia T, Dunbar M, Kirby R, Falotico N, Leverson J, Humerickhouse R, Mabry M, Stone R, Kantarjian H and Letai A. Efficacy and biological correlates of response in a phase ii study of venetoclax monotherapy in patients with acute myelogenous leukemia. Cancer Discov 2016; 6: 1106-1117.","journal-title":"Cancer Discov"},{"key":"ref152","doi-asserted-by":"publisher","unstructured":"Greenhalgh J, Dwan K, Boland A, Bates V, Vecchio F, Dundar Y, Jain P and Green JA. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. Cochrane Database Syst Rev 2016; CD010383.","DOI":"10.1002\/14651858.CD010383.pub2"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"LA Jr","year":"2014","unstructured":"Diaz LA Jr and Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 2014; 32: 579-86.","journal-title":"J Clin Oncol"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","article-title":"Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal","volume":"113","author":"Lauber","year":"2003","unstructured":"Lauber K, Bohn E, Kröber SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G and Wesselborg S. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113: 717-30.","journal-title":"Cell"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1182\/blood-2009-10-243444","article-title":"Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells","volume":"115","author":"Weigert","year":"2010","unstructured":"Weigert A, Cremer S, Schmidt MV, von Knethen A, Angioni C, Geisslinger G and Brüne B. Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood 2010; 115: 3531-40.","journal-title":"Blood"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2008-06-162404","article-title":"CX3CL1\/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis","volume":"112","author":"Truman","year":"2008","unstructured":"Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, Melville L, Melrose LA, Ogden CA, Nibbs R, Graham G, Combadiere C and Gregory CD. CX3CL1\/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 2008; 112: 5026-36.","journal-title":"Blood"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","unstructured":"Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N and Ravichandran KS. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282-6.","journal-title":"Nature"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tcb.2003.10.004","article-title":"Cues for apoptotic cell engulfment: eat-me, don’t eat-me and come-get-me signals","volume":"13","author":"Grimsley","year":"2003","unstructured":"Grimsley C and Ravichandran KS. Cues for apoptotic cell engulfment: eat-me, don’t eat-me and come-get-me signals. Trends Cell Biol 2003; 13: 648-56.","journal-title":"Trends Cell Biol"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1097-2765(04)00237-0","article-title":"Clearance of apoptotic cells: getting rid of the corpses","volume":"14","author":"Lauber","year":"2004","unstructured":"Lauber K, Blumenthal SG, Waibel M and Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004; 14: 277-87.","journal-title":"Mol Cell"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","unstructured":"Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, Yuan J, Zitvogel L, Madeo F, Williams DB and Kroemer G. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28: 578-90.","journal-title":"EMBO J"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cell.2010.02.014","article-title":"Autoimmunity and the clearance of dead cells","volume":"140","author":"Nagata","year":"2010","unstructured":"Nagata S, Hanayama R and Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010; 140: 619-30.","journal-title":"Cell"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/ijms18040741","article-title":"Sphingosine-1-phosphate metabolism and its role in the development of inflammatory bowel disease","volume":"18","author":"Wollny","year":"2017","unstructured":"Wollny T, Wątek M, Durnaś B, Niemirowicz K, Piktel E, Żendzian-Piotrowska M, Góźdź S and Bucki R. Sphingosine-1-phosphate metabolism and its role in the development of inflammatory bowel disease. Int J Mol Sci 2017; 18: 741.","journal-title":"Int J Mol Sci"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"155868","DOI":"10.1016\/j.phymed.2024.155868","article-title":"Linderae Radix extract attenuates ulcerative colitis by inhibiting the JAK\/STAT signaling pathway","volume":"132","author":"Wang","year":"2024","unstructured":"Wang Y, Lai W, Zheng X, Li K, Zhang Y, Pang X, Gao J and Lou Z. Linderae Radix extract attenuates ulcerative colitis by inhibiting the JAK\/STAT signaling pathway. Phytomedicine 2024; 132: 155868.","journal-title":"Phytomedicine"},{"key":"ref164","doi-asserted-by":"publisher","unstructured":"Liu DY, Xu R, Huang MF, Huang HY, Wang X, Zou Y, Yue HY and Zhao HM. Si Shen Wan regulates phospholipase Cγ-1 and PI3K\/Akt signal in colonic mucosa from rats with colitis. Evid Based Complement Alternat Med 2015; 2015: 392405.","DOI":"10.1155\/2015\/392405"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"112404","DOI":"10.1016\/j.intimp.2024.112404","article-title":"Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1\/JAK2\/STAT3 pathway","volume":"137","author":"Bao","year":"2024","unstructured":"Bao X, Tang Y, Lv Y, Fu S, Yang L, Chen Y, Zhou M, Zhu B, Ding Z and Zhou F. Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1\/JAK2\/STAT3 pathway. Int Immunopharmacol 2024; 137: 112404.","journal-title":"Int Immunopharmacol"},{"key":"ref166","doi-asserted-by":"publisher","unstructured":"Wu Y, Jha R, Li A, Liu H, Zhang Z, Zhang C, Zhai Q and Zhang J. Probiotics (Lactobacillus plantarum HNU082) supplementation relieves ulcerative colitis by affecting intestinal barrier functions, immunity-related gene expression, gut microbiota, and metabolic pathways in mice. Microbiol Spectr 2022; 10: e0165122.","DOI":"10.1128\/spectrum.01651-22"},{"key":"ref167","doi-asserted-by":"publisher","unstructured":"Huang C, Dong J, Jin X, Ma H, Zhang D, Wang F, Cheng L, Feng Y, Xiong X, Jiang J, Hu L, Lei M, Wu B and Zhang G. Intestinal anti-inflammatory effects of fuzi-ganjiang herb pair against DSS-induced ulcerative colitis in mice. J Ethnopharmacol,2020; 261: 112951.","DOI":"10.1016\/j.jep.2020.112951"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"153519","DOI":"10.1016\/j.phymed.2021.153519","article-title":"Gegen Qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17\/Treg cell homeostasis via suppressing IL-6\/JAK2\/STAT3 signaling","volume":"84","author":"Zhao","year":"2021","unstructured":"Zhao Y, Luan H, Jiang H, Xu Y, Wu X, Zhang Y and Li R. Gegen Qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17\/Treg cell homeostasis via suppressing IL-6\/JAK2\/STAT3 signaling. Phytomedicine 2021; 84: 153519.","journal-title":"Phytomedicine"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/tox.23837","article-title":"Daphnetin attenuates intestinal inflammation, oxidative stress, and apoptosis in ulcerative colitis via inhibiting REG3A-dependent JAK2\/STAT3 signaling pathway","volume":"38","author":"He","year":"2023","unstructured":"He Z, Liu J and Liu Y. Daphnetin attenuates intestinal inflammation, oxidative stress, and apoptosis in ulcerative colitis via inhibiting REG3A-dependent JAK2\/STAT3 signaling pathway. Environ Toxicol 2023; 38: 2132-2142.","journal-title":"Environ Toxicol"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"117365","DOI":"10.1016\/j.jep.2023.117365","article-title":"Fufangxiaopi formula alleviates DSS-induced colitis in mice by inhibiting inflammatory reaction, protecting intestinal barrier and regulating intestinal microecology","volume":"319","author":"Liu","year":"2024","unstructured":"Liu K, Shi C, Yan C, Yin Y, Qiu L, He S, Chen W and Li G. Fufangxiaopi formula alleviates DSS-induced colitis in mice by inhibiting inflammatory reaction, protecting intestinal barrier and regulating intestinal microecology. J Ethnopharmacol 2024; 319: 117365.","journal-title":"J Ethnopharmacol"},{"key":"ref171","doi-asserted-by":"publisher","unstructured":"Lu H, Shen M, Chen T, Yu Y, Chen Y, Yu Q, Chen X and Xie J. Mesona chinensis benth polysaccharides alleviate DSS-induced ulcerative colitis via inhibiting of TLR4\/MAPK\/NF-κB signaling pathways and modulating intestinal microbiota. Mol Nutr Food Res 2022; 66: e2200047.","DOI":"10.1002\/mnfr.202200047"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"115640","DOI":"10.1016\/j.jep.2022.115640","article-title":"alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota","volume":"298","author":"Shi","year":"2022","unstructured":"Shi G, Kong J, Wang Y, Xuan Z and Xu F. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota. J Ethnopharmacol 2022; 298: 115640.","journal-title":"J Ethnopharmacol"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"113260","DOI":"10.1016\/j.intimp.2024.113260","article-title":"Demethylzeylasteral alleviates inflammation and colitis via dual suppression of NF-κB and STAT3\/5 by targeting IKKα\/β and JAK2","volume":"142","author":"Wen","year":"2024","unstructured":"Wen T, Liu T, Chen H, Liu Q, Shen X and Hu Q. Demethylzeylasteral alleviates inflammation and colitis via dual suppression of NF-κB and STAT3\/5 by targeting IKKα\/β and JAK2. Int Immunopharmacol 2024; 142: 113260.","journal-title":"Int Immunopharmacol"},{"key":"ref174","unstructured":"Duan T, Geng Z, Yang J, Yin L, Sun M, Wang S, Zhang X, Li J, Hu J and Lu G. Isongifolene improves crohn’s disease-like colitis in mice by reducing apoptosis of intestinal epithelial cells. Sichuan Da Xue Xue Bao Yi Xue Ban 2024; 55: 1175-1185."},{"key":"ref175","unstructured":"Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S and Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed 2016; 6: 383-98."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","unstructured":"Hatcher H, Planalp R, Cho J, Torti FM and Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65: 1631-52.","journal-title":"Cell Mol Life Sci"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"102469","DOI":"10.1016\/j.redox.2022.102469","article-title":"MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT","volume":"56","author":"Zhang","year":"2022","unstructured":"Zhang J, Cen L, Zhang X, Tang C, Chen Y, Zhang Y, Yu M, Lu C, Li M, Li S, Lin B, Zhang T, Song X, Yu C, Wu H and Shen Z. MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT. Redox Biol 2022; 56: 102469.","journal-title":"Redox Biol"},{"key":"ref178","doi-asserted-by":"publisher","unstructured":"Danese S, Grisham M, Hodge J and Telliez JB. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol 2016; 310: G155-62.","DOI":"10.1152\/ajpgi.00311.2015"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0166302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:00Z","timestamp":1766023020000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0166302.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":179,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ncff5626","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}